Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Atherosclerosis|January 22, 2013
Rapid regression of atherosclerosis with MTP inhibitor treatmentBernd Hewing, Saj Parathath, Christina K Mai, et al.
Transplantation|August 2, 2007
Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirinCarmen M Stanca, M Isabel Fiel, Nickolas Kontorinis, et al.
American Journal of Clinical Pathology|March 18, 2015
Primary sclerosing cholangitis: detailed histologic assessment and integration using bioinformatics highlights arterial fibrointimal hyperplasia as a novel featureGonzalo Carrasco-Avino, Thomas D Schiano, Stephen C Ward, et al.
Histopathology|January 30, 2020
Aberrant von Willebrand factor expression of sinusoidal endothelial cells and quiescence of hepatic stellate cells in nodular regenerative hyperplasia and obliterative portal venopathyXuchen Zhang, Courtney Thomas, Thomas D Schiano, et al.
BMC Medicine|December 8, 2017
A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosisSeungyeul Yoo, Wenhui Wang, Qin Wang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 30, 2008
Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virusM Isabel Fiel, Kaushik Agarwal, Carmen Stanca, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|April 30, 2021
Evaluation of the fibrosis-4 index for detection of advanced fibrosis among individuals at risk for intestinal failure-associated liver diseaseDejan Micic, Genevieve Huard, Sang Mee Lee, et al.
Annals of Surgical Oncology|June 18, 2013
Impact of intrahepatic hepatitis B DNA and covalently closed circular DNA on survival after hepatectomy in HBV-associated hepatocellular carcinoma patientsQin Wang, M Isabel Fiel, Wei Luan, et al.
Plos One|January 4, 2021
Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of ErysipelotrichalesJames K Carter, Dipankar Bhattacharya, Joshua N Borgerding, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 5, 2008
Regression of hepatic fibrosis after intestinal transplantation in total parenteral nutrition liver diseaseM Isabel Fiel, Bernhard Sauter, Hai-Shan Wu, et al.
Pageof 12